In addition, Vδ2 T cells from autologous peripheral blood co-cultured with CRC organoids could proliferate in response to the therapeutic anti-epidermal growth factor receptor (EGFR) antibody Cetuximab conjugated with zoledronate (Cet-ZA). The gene discussed is EGFR; the disease is colorectal carcinoma.